|
| 36730050 | Spike Gene Target Amplification in a Diagnostic Assay as a Marker for Public Health Monitoring of Emerging SARS-CoV-2 Variants - United States, November 2021-January 2023. | MMWR Morb Mortal Wkly Rep | 2023 |
| 37958688 | Monoclonal Antibodies as SARS-CoV-2 Serology Standards: Experimental Validation and Broader Implications for Correlates of Protection. | Int J Mol Sci | 2023 |
| 37662226 | SARS-CoV-2 shedding and evolution in immunocompromised hosts during the Omicron period: a multicenter prospective analysis. | medRxiv | 2023 |
| 37622664 | Annual (2023) taxonomic update of RNA-directed RNA polymerase-encoding negative-sense RNA viruses (realm <i>Riboviria</i>: kingdom <i>Orthornavirae</i>: phylum <i>Negarnaviricota</i>). | J Gen Virol | 2023 |
| 35591770 | Characteristics of nursing home residents and healthcare personnel with repeated severe acute respiratory coronavirus virus 2 (SARS-CoV-2) tests positive â¿¥90 days after initial infection: Four US jurisdictions, July 2020-March 2021. | Infect Control Hosp Epidemiol | 2023 |
| 37319011 | Genomic Surveillance for SARS-CoV-2 Variants: Circulation of Omicron Lineages - United States, January 2022-May 2023. | MMWR Morb Mortal Wkly Rep | 2023 |
| 37187508 | Neutralizing Antibody Responses to Messenger RNA Coronavirus Disease 2019 Vaccines Versus Severe Acute Respiratory Syndrome Coronavirus 2 Infection Among Pregnant Women and Vaccine-Induced Antibody Transfer to Infants. | Open Forum Infect Dis | 2023 |
| 37347180 | Evaluation of Ortho VITROS and Roche Elecsys S and NC Immunoassays for SARS-CoV-2 Serosurveillance Applications. | Microbiol Spectr | 2023 |
| 37313727 | Respiratory Syncytial Virus Infection Among Hospitalized Infants in Four Middle-Income Countries. | J Pediatric Infect Dis Soc | 2023 |
| 37246146 | Prior SARS-CoV-2 infection and COVID-19 vaccine effectiveness against outpatient illness during widespread circulation of SARS-CoV-2 Omicron variant, US Flu VE network. | Influenza Other Respir Viruses | 2023 |
| 37277736 | Assessment of Anti-SARS-CoV-2 antibody levels among university students vaccinated with different COVID-19 primary and booster doses - fall 2021, Wisconsin. | BMC Infect Dis | 2023 |
| 37167154 | COVID-19 Surveillance After Expiration of the Public Health Emergency Declaration - United States, May 11, 2023. | MMWR Morb Mortal Wkly Rep | 2023 |
| 36883903 | Total and Subgenomic RNA Viral Load in Patients Infected With SARS-CoV-2 Alpha, Delta, and Omicron Variants. | J Infect Dis | 2023 |
| 36479424 | Estimated SARS-CoV-2 antibody seroprevalence trends and relationship to reported case prevalence from a repeated, cross-sectional study in the 50 states and the District of Columbia, United States-October 25, 2020-February 26, 2022. | Lancet Reg Health Am | 2023 |
| 36578137 | Severe Acute Respiratory Syndrome Coronavirus 2 Infection History and Antibody Response to 3 Coronavirus Disease 2019 Messenger RNA Vaccine Doses. | Clin Infect Dis | 2023 |
| 33988220 | Evaluating the Presence of Replication-Competent Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) From Nursing Home Residents With Persistently Positive Reverse Transcription Polymerase Chain Reaction (RT-PCR) Results. | Clin Infect Dis | 2022 |
| 35803846 | SARS-CoV-2 infection risk among vaccinated and unvaccinated household members during the Alpha variant surge - Denver, Colorado, and San Diego, California, January-April 2021. | Vaccine | 2022 |
| 35442437 | Surveillance and Correlation of Severe Acute Respiratory Syndrome Coronavirus 2 Viral RNA, Antigen, Virus Isolation, and Self-Reported Symptoms in a Longitudinal Study With Daily Sampling. | Clin Infect Dis | 2022 |
| 35703309 | Active Surveillance With Seroprevalence-based Infection Rates Indicates Racial Disparities With Pediatric SARS-CoV-2 Requiring Hospitalization in Mississippi, March 2020-February 2021. | Pediatr Infect Dis J | 2022 |
| 35856710 | SARS-CoV-2 Convalescent Sera Binding and Neutralizing Antibody Concentrations Compared with COVID-19 Vaccine Efficacy Estimates against Symptomatic Infection. | Microbiol Spectr | 2022 |
| 35447121 | Household Transmission and Symptomology of Severe Acute Respiratory Syndrome Coronavirus 2 Alpha Variant among Children-California and Colorado, 2021. | J Pediatr | 2022 |
| 36437428 | 2022 taxonomic update of phylum Negarnaviricota (Riboviria: Orthornavirae), including the large orders Bunyavirales and Mononegavirales. | Arch Virol | 2022 |
| 36457114 | Evaluation of self-administered antigen testing in a college setting. | Virol J | 2022 |
| 36215247 | Household characteristics associated with surface contamination of SARS-CoV-2 and frequency of RT-PCR and viral culture positivity-California and Colorado, 2021. | PLoS One | 2022 |
| 35873297 | Examination of Common Coronavirus Antibodies in SARS-CoV-2-Infected and Uninfected Participants in a Household Transmission Investigation. | Open Forum Infect Dis | 2022 |
| 36301805 | Longitudinal serologic and viral testing post-SARS-CoV-2 infection and post-receipt of mRNA COVID-19 vaccine in a nursing home cohort-Georgia, October 2020â¿¿April 2021. | PLoS One | 2022 |
| 36016365 | Outbreak of Middle East Respiratory Syndrome Coronavirus in Camels and Probable Spillover Infection to Humans in Kenya. | Viruses | 2022 |
| 36220174 | Vaccine effectiveness of primary series and booster doses against covid-19 associated hospital admissions in the United States: living test negative design study. | BMJ | 2022 |
| 35202532 | Relationship of SARS-CoV-2 Antigen and Reverse Transcription PCR Positivity for Viral Cultures. | Emerg Infect Dis | 2022 |
| 35202525 | Evaluation of Commercially Available High-Throughput SARS-CoV-2 Serologic Assays for Serosurveillance and Related Applications. | Emerg Infect Dis | 2022 |
| 35141347 | Twelve-Month Follow-up of Early COVID-19 Cases in the United States: Cellular and Humoral Immune Longevity. | Open Forum Infect Dis | 2022 |
| 34928334 | Neutralizing Antibody Response to Pseudotype Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Differs Between mRNA-1273 and BNT162b2 Coronavirus Disease 2019 (COVID-19) Vaccines and by History of SARS-CoV-2 Infection. | Clin Infect Dis | 2022 |
| 35019677 | A Trans-Governmental Collaboration to Independently Evaluate SARS-CoV-2 Serology Assays. | Microbiol Spectr | 2022 |
| 35228262 | Development and Validation of an Enzyme Immunoassay for Detection and Quantification of SARS-CoV-2 Salivary IgA and IgG. | J Immunol | 2022 |
| 34412728 | Repeated antigen testing among severe acute respiratory coronavirus virus 2 (SARS-CoV-2)-positive nursing home residents. | Infect Control Hosp Epidemiol | 2022 |
| 34673119 | Next-generation sequencing of human respiratory syncytial virus subgroups A and B genomes. | J Virol Methods | 2022 |
| 34802478 | Descriptive evaluation of antibody responses to severe acute respiratory coronavirus virus 2 (SARS-CoV-2) infection in plasma and gingival crevicular fluid in a nursing home cohort-Arkansas, June-August 2020. | Infect Control Hosp Epidemiol | 2022 |
| 34216468 | Epidemiologic, Immunologic, and Virus Characteristics in Patients With Paired Severe Acute Respiratory Syndrome Coronavirus 2 Serology and Reverse-Transcription Polymerase Chain Reaction Testing. | J Infect Dis | 2022 |
| 32249314 | Multiple Respiratory Syncytial Virus Introductions Into a Neonatal Intensive Care Unit. | J Pediatric Infect Dis Soc | 2021 |
| 35419540 | Clinical Course of SARS-CoV-2 Infection in Adults with ESKD Receiving Outpatient Hemodialysis. | Kidney360 | 2021 |
| 33576746 | Pediatric Respiratory and Enteric Virus Acquisition and Immunogenesis in US Mothers and Children Aged 0-2: PREVAIL Cohort Study. | JMIR Res Protoc | 2021 |
| 33909063 | A Comparison of Less Invasive Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Diagnostic Specimens in Nursing Home Residents-Arkansas, June-August 2020. | Clin Infect Dis | 2021 |
| 33598716 | Clinical and Laboratory Findings in Patients With Potential Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Reinfection, May-July 2020. | Clin Infect Dis | 2021 |
| 33846714 | Epidemiologic Characteristics Associated With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antigen-Based Test Results, Real-Time Reverse Transcription Polymerase Chain Reaction (rRT-PCR) Cycle Threshold Values, Subgenomic RNA, and Viral Culture Results From University Testing. | Clin Infect Dis | 2021 |
| 33594367 | Surface-aerosol stability and pathogenicity of diverse MERS-CoV strains from 2012 - 2018. | bioRxiv | 2021 |
| 33900165 | Susceptibility to SARS-CoV-2 of Cell Lines and Substrates Commonly Used to Diagnose and Isolate Influenza and Other Viruses. | Emerg Infect Dis | 2021 |
| 33639620 | Changes in Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence Over Time in 10 Sites in the United States, March-August, 2020. | Clin Infect Dis | 2021 |
| 33754992 | Low-Level Middle East Respiratory Syndrome Coronavirus among Camel Handlers, Kenya, 2019. | Emerg Infect Dis | 2021 |
| 33693830 | Shedding of Culturable Virus, Seroconversion, and 6-Month Follow-up Antibody Responses in the First 14 Confirmed Cases of Coronavirus Disease 2019 in the United States. | J Infect Dis | 2021 |
| 33723510 | Infectious Period of Severe Acute Respiratory Syndrome Coronavirus 2 in 17 Nursing Home Residents-Arkansas, June-August 2020. | Open Forum Infect Dis | 2021 |